Walburn, Jessica, Norton, Sam ORCID: https://orcid.org/0000-0003-1714-9963, Sarkany, Robert, Canfield, Martha, Sainsbury, Kirby, Mccrone, Paul ORCID: https://orcid.org/0000-0001-7001-4502, Araújo-Soares, Vera, Morgan, Myfanwy, Boadu, Janette, Foster, Lesley, Heydenreich, Jakob, Mander, Adrian P, Sniehotta, Falko F, Wulf, Hans Christian and Weinman, John (2024) A personalised and systematically designed adherence intervention improves photoprotection in adults with Xeroderma Pigmentosum (XP): results of the XPAND randomised controlled trial. British Journal of Dermatology (BJD):ljae393. ISSN 0007-0963 (Print), 1365-2133 (Online) (doi:10.1093/bjd/ljae393)

Preview	PDF (Published Online Open Access AAM) 49414 McCRONE_A_Personalised_And_Systematically_Designed_Adherence_Intervention_Improves_Photoprotection_In_Adults_With_Xeroderma_Pigmentosum_XP_(AAM)_2024.pdf - Accepted Version Available under License Creative Commons Attribution. Download (719kB) | Preview
Preview	PDF (Supplemental Material) 49414 McCRONE_A_Personalised_And_Systematically_Designed_Adherence_Intervention_Improves_Photoprotection_In_Adults_With_Xeroderma_Pigmentosum_XP_(SUPPLEMENTAL)_2024.pdf - Supplemental Material Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Background: Poor adherence to photoprotection in Xeroderma Pigmentosum (XP) increases morbidity and shortens lifespan due to skin cancers.
Objective: To test a highly personalised intervention (XPAND) to reduce the dose of ultraviolet radiation (UVR) reaching the face in adults with XP, designed using known psychosocial determinants of poor photoprotection.
Methods: A two-arm parallel group randomised controlled trial, including patients with sub-optimal photoprotection to receive XPAND or a delayed intervention control arm that received XPAND the following year. XPAND comprises seven one-to-one sessions targeting photoprotection barriers (e.g., misconceptions about UVR) supported by personalised text messages, activity sheets, and educational materials incorporating behaviour change techniques. The primary outcome, mean daily UVR dose-to-face across 21 days in June-July 2018, was calculated by combining UVR exposure at the wrist with a face photoprotection activity diary. Secondary outcomes were UVR dose-to-face across 21 days in August 2018, time spent outside, photoprotective measures used outside, mood, automaticity, confidence-to-photoprotect. Financial costs and quality-adjusted life years (QALYs) were calculated.
Results: 16 patients were randomised, 13 provided sufficient data for primary outcome analysis. The XPAND group (n=8) had lower mean daily UVR dose-to-face [0.03 SED (SD 0.02] compared to control (n=7) [0.36 SED (SD 0.16)] (adjusted difference=-0.25, p<0.001, Hedge’s g=2.2). No significant between-group differences were observed in time spent outside, photoprotection outside, mood, or confidence. The delayed intervention control showed improvements in UVR dose-to-face (adjusted difference=-0.05, Hedge’s g=-0.1) , time outside (adjusted difference=-69.9, Hedge’s g=-0.28), and photoprotection (adjusted difference=-0.23, Hedge’s g=0.45), after receiving XPAND. XPAND was associated with lower treatment costs (£-2642; 95% CI: -£8715 to £3873) and fewer QALYs (-0.0141; 95% CI: -0.0369 to 0.0028).
Conclusions: XPAND was associated with a lower UVR dose-to-face in XP patients and was cost-effective.

Item Type:	Article
Additional Information:	This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Uncontrolled Keywords:	cost, dermatology
Subjects:	R Medicine > R Medicine (General) R Medicine > RL Dermatology
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development > Centre for Mental Health Faculty of Education, Health & Human Sciences > School of Health Sciences (HEA)
Last Modified:	15 Jan 2025 15:25
URI:	http://gala.gre.ac.uk/id/eprint/49414

Actions (login required)

View Item

Downloads